key: cord-0730530-snm1yxo8
authors: Nguyen, Tam Thi; Pham, Thach Ngoc; Van, Trang Dinh; Nguyen, Trang Thu; Nguyen, Diep Thi Ngoc; Le, Hoa Nguyen Minh; Eden, John-Sebastian; Rockett, Rebecca J.; Nguyen, Thuong Thi Hong; Vu, Bich Thi Ngoc; Tran, Giang Van; Le, Tan Van; Dwyer, Dominic E.; van Doorn, H. Rogier
title: Genetic diversity of SARS-CoV-2 and clinical, epidemiological characteristics of COVID-19 patients in Hanoi, Vietnam
date: 2020-11-17
journal: PLoS One
DOI: 10.1371/journal.pone.0242537
sha: 69dc4be6b41a5ce97d8d7ed029facf8ee560b972
doc_id: 730530
cord_uid: snm1yxo8

A second cluster of COVID-19 cases imported from Europe occured in Vietnam from early March 2020. We describe 44 SARS-CoV-2 RT-PCR positive patients (cycle threshold value <30) admitted to the National Hospital for Tropical Diseases in Hanoi between March 6 and April 15 2020. Whole SARS-CoV-2 genomes from these patients were sequenced using Illumina Miseq and analysed for common genetic variants and relationships to local and globally circulating strains. Results showed that 32 cases were Vietnamese with a median age of 37 years (range 15–74 years), and 23 were male. Most cases were acquired outside Vietnam, mainly from the UK (n = 15), other European countries (n = 14), Russia (n = 6) and countries in Asia (n = 3). No cases had travelled from China. Forty-one cases had symptoms at admission, typically dry cough (n = 36), fever (n = 20), sore throat (n = 14) and diarrhoea (n = 12). Hospitalisation was long with a median of 25 days, most commonly from 20–29 days. All SARS-CoV-2 genomes were similar (92–100% sequence homology) to the reference sequence Wuhan_1 (NC_045512), and 32 strains belonged to the B.1.1 lineage. The three most common variants were linked, and included C3037T, C14408T (nsp12: P323L) and A23403G (S: D614G) mutations. This group of mutations often accompanied variant C241T (39/44 genomes) or GGG 28881..28883 AAC (33/44 genomes). The prevalence of the former reflected probable European origin of viruses, and the transition D614G was dominant in Vietnam. New variants were identified; however, none could be associated with disease severity.

a1111111111 a1111111111 a1111111111 a1111111111 a1111111111

Coronavirus Disease 2019 is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and has spread to 218 countries and territories worldwide, leading to more than 42,500,000 confirmed cases with 1,147,301 deaths by October 25 2020 [1] . The number of deaths due to COVID-19 has increased significantly since April 2020, with between 3000 to 6000 deaths daily [2] .

SARS-CoV-2 belongs to family Coronaviridae, genus Betacoronavirus and subgenus Sarbecovirus, and is one of seven coronaviruses causing human disease-NL63, 229E, OC43, HKU1, SARS-CoV and Middle East Respiratory Syndrome CoV (MERS-CoV) [3] . The SARS-CoV-2 genome has about 89% nucleotide sequence similarity with SARS-like CoVs (bat SL-CoVZC45, SARS-CoV Tor2) and is divided into two untranslated terminal regions (UTR) and 14 open reading frames (ORFs). The structural ORFs consist of Spike (S), Envelope (E), Membrane (M) and Nucleocapsid (N) proteins, while other regions code for non-structural or accessory proteins [4] .

On January 23 2020, the Ministry of Health in Vietnam reported the first imported case of SARS-CoV-2 infection, someone who had recently travelled from Wuhan in Hubei Province, China. A total of 16 cases were recorded in this first cluster, but more SARS-CoV-2 importation and transmission in Vietnam happened from March 2020 onward, when residents and tourists entered Vietnam from Europe, USA and elsewhere in Asia [5] . Notably, local community transmission was successfully suppressed for 99 days from the April 15 to July 24 2020 [5] . The cases recently detected in Da Nang have triggered the third cluster of COVID-19 in Vietnam, increasing local and hospital acquired transmission and deaths. There are a number of reports describing the clinical, epidemiological and genetic features of COVID-19 cases and SARS-CoV-2 in Vietnam, although whole genome sequencing (WGS) data is limited [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] . Here, we report the clinical, epidemiological and WGS features and correlations of 44 patients with COVID-19 in Vietnam.

Nasopharyngeal and oropharyngeal swabs of all suspected COVID-19 cases quarantined or hospitalised/isolated at the National Hospital for Tropical Diseases (NHTD) were collected using sterile cotton buds and stored in in-house produced viral transport medium. Samples were tested within 24 hours of collection. Total RNA was extracted with the QIAamp viral RNA mini kit (Qiagen, Hilden, Germany) and tested with a real-time reverse transcription PCR (real-time RT-PCR) to check for the presence of the E gene (112bp) and RNA-dependent RNA polymerase (RdRp) gene (99bp) according to the World Health Organization's protocol using SuperScript III Platinum One-Step qRT-PCR kit (Invitrogen, Carlsbad, CA USA) and E-Sarbeco, RdRp primers and probes (Tib Molbiol, Berlin, Germany) [19] . Positive samples with cycle threshold (Ct) values <30 for both genes were stored at -80˚C for sequencing.

RNA was converted into cDNA, then amplified into 14 PCR products spanning the SARS--CoV-2 reference genome (Accession: MN 908947-Wuhan-Hu-1). PCR products (about 2.5kb) were checked by electrophoresis using a 1% agarose gel running at 110V for 30 minutes. PCR fragments of each sample were then pooled and purified by AMPure XP beads (Beckman Coulter, USA).

Library preparation used the Nextera XT Library preparation kit (Illumina, USA), and sequencing was performed on an Illumina Miseq platform with the 300 cycle v2 or 300 cycle micro v2 kit (Illumina, USA) following manufacturer's instructions.

Real-time RT PCR positive patients were admitted to the NHTD, the first-line national hospital for COVID-19 treatment in northern Vietnam. Medical staff recorded patient demographics, travel history and contacts within the previous 14 days. Admission signs, symptoms and health history were obtained by direct patient communication, and followed up during hospitalisation. Treatments, chest radiography or computed tomography (CT) and clinical outcomes of 44 patients were recorded. This study was approved by the Institutional Review Board of the National Hospital for Tropical Diseases, Hanoi, Vietnam. The need for participant consent was waived by the Ethics Committee of the National Hospital for Tropical Diseases (Decision No.02A/HDDD-NDTU issued on March 30 2020).

Consensus assembly and variant detection. A quality control, assembly and variant calling workflow for Illumina data with the Nextera XT library preparation kit was used [22] . The workflow performed on CLC genomics workbench version 20.0.3 included raw reads firstly trimmed based on read quality and to remove adapters. Trimmed reads were mapped to a data set of eight SARS-CoV-2 genomes from Vietnam in March 2020 submitted to GISAID (https://www. gisaid.org/). This resulted in reads specific to SARS-CoV-2 and non-SARS-CoV-2 reads which primarily mapped to the human reference genome (GCA_000001405.15_GRCh38). Viral reads were mapped to the Wuhan SARS-CoV-2 reference genome (NC_045512) producing a consensus sequence and calling sequence variants of 44 viral isolates. The workflow finally created reports (tables or graphic files) and a track list to summarise results of all steps. Based on variant/amino acid change tables, we filtered true mutations which met a coverage of >30x and greater than 70% of total reads carrying the modification. Novel variants and deletions were confirmed by Sanger sequencing.

The viral consensus sequences were submitted to the GLUE website (http://cov-glue.cvr. gla.ac.uk) to confirm whether any mutations were novel compared to the GISAID database. We combined the mutation report from GLUE with CLC genomics workbench to remove modifications that did not satisfy the threshold for mutation selection. QualiMap application [23] was used to evaluate sequencing depth across the reference genome and calculate mean coverage values.

Phylogenetic analysis of study sequences in global context. The study sequences were genotyped using the Pangolin [24] web server (https://pangolin.cog-uk.io/), which revealed that all 44 viruses were of the SARS-CoV-2 B lineage. To examine the diversity and potential sources, study sequences were compared to a random selection of 1000 globally circulating B lineage viruses and other Vietnamese sequences (41 sequences including 5 A lineage viruses) available on GISAID with collection dates reflecting the study period between December 1st 2019 and April 15th 2020. All sequences were first aligned against the prototype strain Wuhan-Hu-1/2019 (GenBank accession NC_045512) with MAFFT [25] before sequences with excessive ambiguities (>400 sites) and divergence (>25 SNPs from prototype) were removed along with those without a specific day of sample collection. The refined alignment was then analysed phylogenetically using a maximum likelihood approach in RAxML [26] with the GTR+G substitution model and 1000 bootstrap replicates. The final tree was visualised and annotated with FigTree [27] . Cluster identification was based on the phylogenetic analysis showing monophyletic clades with a bootstrap value greater than 70.

Metadata analysis. Metadata distributed in range and continuously, and their mean and standard deviation (SD) values were reported. Other categorical variables were counted and percentage given per total sample. Microsoft Excel was used to statistically analyze these data.

This study enrolled 44 patients who were selected for inclusion based on a positive SARS--CoV-2 real-time RT PCR result with Ct values of E and RdRp gene <30. The median age of all patients was 37 years (range 15-74), with the 20-39 years age group the most prevalent, accounting for 20 cases (Table 1) . Thirty-two patients were of Vietnamese nationality, and the imported cases had travelled from United Kingdom (n = 15), Russia (n = 6), Germany (n = 5), France (n = 4), Italy (n = 2), Spain (n = 2), Netherlands (n = 1) and countries in Asia (n = 3). The male:female ratio was 23:21.

In terms of epidemiology, the majority of patients were imported cases (25/44) entering Vietnam from March to April 2020. These cases included returning travellers from Europe, especially the UK. There were no cases from China. While most imported cases (n = 17) were quarantined immediately, 8 cases had contact with relatives and community before SARS-CoV-2 detection and isolation at the NHTD. There were 12 cases infected following contact with positive cases in Vietnam, another five cases were acquired from either international sources or other known contacts, whereas for two cases contact details were unavailable (Table 1) .

According to the WHO definition [28] , we identified symptomatic cases as laboratory-confirmed people displaying any symptoms or signs of respiratory viral infection at admission. Laboratory-confirmed cases not having any symptoms at diagnosis and at 14 day follow-up were classified as asymptomatic. Pre-symptomatic cases were defined as a laboratory-confirmed case who did not have symptoms at diagnosis but developed clinical symptoms within 14 days. Forty-one cases were symptomatic with dry cough (n = 36), fever (n = 20), sore throat (n = 14), diarrhoea (n = 12); there were a few cases with headache, difficulty breathing, muscle aches and fatigue (Table 2 ). Most patients did not have underlying chronic medical diseases, but 10 had co-morbidities including cancer, diabetes, asthma, hypertension, chronic kidney disease, cerebrovascular disease, gout, vestibular disorder, heart failure or gastroesophageal reflux. There were 34 cases diagnosed with pneumonia based on chest X-ray or CT abnormalities (Table 2) : one case had an asymptomatic pneumonia. Notably, four patients developed critical illness with respiratory failure requiring initial oxygen supplementation, invasive intubation (four cases, 9%), with one switched to extracorporeal membrane oxygenation (Table 2 and S1  Table) . Only one of the four critically ill patients did not have any underlying chronic disease (S1 Table) . Critically ill patients were moved to the intensive care unit (ICU), and transferred to another department when recovering.

In terms of the treatment course, 11 patients were treated with antibiotics, and three of the ICU patients received antifungals and glucocorticoids. Apart from the four critical cases, two patients required non-mechanical oxygenation. Two patients needed renal dialysis, one of whom had a history of chronic kidney disease. Intravenous immunoglobulin (IVIG) was given to five patients (Table 2) . Treatment duration was around 25 days, with 17 cases between 20-29 days. Five cases needed under 10 days to recover, while two cases stayed in hospital for up to 79 days. All patients recovered and were discharged home.

Forty-four complete SARS-CoV-2 sequences were produced using an amplicon-based approach. For each sequence library, 92-100% of paired end reads mapped to the reference genome sequence (NC_045512). Lengths varied between 29,777 and 29,872 base pairs (bp) at sequencing depths (average coverage across the whole reference genome) greater than 2000x ( Table 3 ). All sequences were submitted to GISAID (https://www.gisaid.org/) with accession numbers listed in S2 Table. When compared to all GISAID sequences, our sequences fell into six lineages including B.1, B.1.1, B.1.1.1, B.2, B.2.1 and B.3 , with the dominant lineage being B.1.1 (32/44) (Fig 1) . Among the 32 B.1.1 viruses, eleven were isolated from patients who were contacts of positive cases in the community, four were from patients reporting both international travel (from UK and Germany) and contact with positive cases, 16 were from imported cases (UK six cases, Germany two, Russia three, and one case each from Italy, France, Netherlands, Spain and Japan). Two cases with unknown transmission source had B.1 and B.1.1 lineage sequences (S3 Table) .

Although our sequences were mostly from B.1 viruses, and particularly the B.1.1 lineage, the sequences were relatively dispersed across the phylogeny. There were two notable clusters observed within the B.1.1 lineage: cluster 1 included three samples (VNHN_5152, VNHN_4875, VNHN_4868) and cluster 2 consisted of five samples (VNHN_3085, VNHN_3913, VNHN_3916, VNHN_4864, VNHN_4958) (S1 Fig) . Cluster 1 sequences differed from each other at one SNP or one deletion of three nucleotides, while four sequences in cluster 2 were identical and another sequence had a 6-nucleotide deletion compared to others. Interestingly, all samples in cluster 1 were isolated from locally transmitted cases in a local hotspot in Vietnam, and included members of the same family and a neighbour. Cases in cluster 2 were residents returning from different countries: three of them were on the same flight from Germany, one from Japan and the other from Spain. A comparison of our sequences to 41 other Vietnamese sequences on GISAID collected between January and April 2020 showed little if any grouping suggesting most were unique importation events and there was little, if any, mixing between the northern (this study) and southern parts of Vietnam (S1 Fig). 

Using CLC genomics workbench, we identified 285 mutations covering 67 variant types among the 44 SARS-CoV-2 genomes when compared to the reference genome, averaging 6.5 variants per genome. Sixty-one variants were single nucleotide substitutions, causing 36 non- 

Genetic, clinical and epidemiological characteristics of COVID-19 in Hanoi, Vietnam (Table 4 ). The most ubiquitous modifications were C3037T, C14408T (P323L) and A23403G (D614G) occurring in 40/44 samples. Two other variants C241T and GGG to AAC at 28881-3 were detected in 39 and 33 sequences, respectively. These variants are key markers to define lineages B.1 (C241T, C3037T, A23403G) and B.1.1 (C241T, C3037T, A23403G, GGG28881..28883AAC), the major lineages in our study. The most common variants were detected in viral sequences amplified from patients with both mild disease and in the ICU. There were three deletions of 15, six and three nucleotides, resulting in loss of five, two and one amino acids respectively, while two deletions of one or two nucleotides led to frameshifts. No insertions among the 44 genome sequences were detected. Two novel mutations were associated with frameshifts as mentioned previously, the others were non-synonymous changes, namely C4733T (L672F) and A29122C (Q283H). Novel mutations occurred in non-structural protein 3 (ORF 1a), open reading frame 7b and N coding regions on SARS-CoV-2 genome, and were detected in three different genomes (VNHN_0148, VNHN_0762, VNHN_1166). These mutations were not associated with differences in phenotype of illness, although numbers were small.

There were 14 ORFs across the SARS-CoV-2 genome [4] . Mutations detected in our study often occurred in the nsp3 region (ORF1ab) with nine variant types, followed by N, S and nsp2 regions with four variant types ( Table 4 ). The conservative coding regions without any modifications were E, ORF6, ORF8 and ORF10. Notably, four types of mutations detected in the Spike gene did not occur in the receptor binding domain (RBD: residue 319-541) that binds to the human receptor hACE2 for viral entry [3] .

NHTD is a front-line national hospital in Hanoi for isolation and treatment of laboratory-confirmed COVID-19 cases for the northern part of Vietnam. Forty-four SARS-CoV-2 RT-PCR patients with Ct values <30 had SARS-CoV-2 WGS performed with the aim of characterising lineages and identifying mutations in patients with different transmission sources in Vietnam. This study also describes the clinical and epidemiological features, treatment and outcomes of 44 COVID-19 patients.

The ages, gender and origins of COVID-19 disease are consistent with a Vietnamese Ministry of Health report summarising the demographic and epidemiological data of 207 COVID-19 cases in Vietnam from January 23 to May 1 2020 [5] . Among our 44 patients, 41 had respiratory symptoms on admission. In a study in southern Vietnam conducted in a quarantine facility rather than a referral hospital, only 57% of patients reported symptoms [18] . This difference may be due to characteristics of patients varying between a national hospital and government quarantine centres, or due to sample selection: we examined patients with Ct <30 in the real-time RT PCR, thus possibly not representing all cases at the NHTD. Common symptoms such as dry cough and fever reported in our study are similar to earlier reports of COVID-19 in China [29, 30] and Vietnam [7, 9, 16] . However, most patients did not have underlying chronic diseases, and most (77%) had pneumonia with abnormalities on chest imaging, including one asymptomatic case. The median hospital stay was 25 days, which was longer than that of other reports from Vietnam of either 14-19 or 15-18 days [8, 13] .

The SARS-CoV-2 genomes in our study are complete, high coverage sequences, accounting for more than 50% of available Vietnamese genomes of SARS-CoV-2 submitted to GISAID to date. Our phylogenetic analysis of 85 SARS-CoV-2 sequences from Vietnam collected up to April 15th 2020 submitted to GISAID showed almost all were B.1 lineage and sublineages. Most of our viral genomes belonged to the B.1.1 lineage, the dominant lineage in the UK as Fig). In addition, viruses within each region in Vietnam did not cluster together but with sequences from other countries, suggesting multiple introduction events and limited local transmission. We characterised the three most prevalent variants detected in 40/44 completed genome sequences, namely C3037T (synonymous substitution) and two non-synonymous mutations C14408T (nsp12: P323L), A23403G (S: D614G). Another study analysed over 10,000 SARS--CoV-2 genomes from 68 countries from four databases showed an identical result, with over 6000 sequences carrying these three variants [32] . Interestingly, these three variants always occurred together, and sometimes they were accompanied by a synonymous mutation C241T (in 39 genomes) or multiple nucleotide substitutions GGG28881..28883AAC (N: R203K, G204R; in 33 genomes), suggesting linkage of mutations among these strains. The prevalence of these mutations was consistent with major lineages identified in this study. The linkage of four changes (C241T, C3037T, C14408T, A23403T) has been described in a comprehensive study of Spike protein variants especially related to the D614G transition [33] . The D614G mutation was first detected in a SARS-CoV-2 sequence from Germany in January 2020 [34] . Subsequently, haplotypes combining these four variants appeared in Italy in February 2020, then spread throughout Europe and currently account for 78% of worldwide sequences submitted to GISAID (May 29 2020), forming the G614 SARS-CoV-2 strain [33] . Of the SARS-CoV-2 genomes from the first two patients in Vietnam (one from Wuhan who transmitted to a second case), the D614G change was not found [9] . The B.1 lineage and its sublineages have formed the majority of sequences from Vietnam since March 2020 (S1 Fig) and harbour D614G. The current variants detected in our study together with other genome sequences indicate a similar trend of transition of D614 to G614 in Vietnam, which confirms that the main transmission source of COVID-19 here was from Europe rather than from China (where the progenitor D614 strains predominate). The study by Kyogama et al. [32] agreed with our finding that nsp3 protein (ORF1ab) most usually occurred as mis-sense variants. We did not find mutations in the E, ORF6, ORF8 and ORF10 coding regions. We identified other mutations on the Spike protein (L54F, S254F, C1250F), however these changes did not occur in the receptor binding domain. Four new unique variants were detected in three SARS-CoV-2 genomes in our study, including C4733T (nsp3: L672F), A29122C (N: Q283H), deletion TT 27792..27793 (OFR7b: Leu14 frameshift) and deletion T 5514 (nsp3: Val931 frameshift). However, we did not find a link between these new mutations and disease severity.

This study provides an insight into the clinical features of COVID-19 and evolutionary trends of SARS-CoV-2 in Vietnam. Genomic surveillance combined with field epidemiology will remain crucial to track and trace transmission. 

Coronavirus disease (COVID-19) pandemic

Structural and functional basis of SARS-CoV-2 entry by using human ACE2

A new coronavirus associated with human respiratory disease in China

The first 100 days of SARS-CoV-2 control in Vietnam

From first COVID-19 case to current outbreak: a Vietnamese report

Early release-Severe Acute Respiratory Syndrome Coronavirus 2 shedding by travelers

Describing the pattern of the COVID-19 epidemic in Vietnam

Clinical features, isolation, and complete genome sequence of severe acute respiratory syndrome coronavirus 2 from the first two patients in Vietnam

Factors associated with the duration of hospitalization among COVID-19 patients in Vietnam: A survival analysis

Epidemiological Characteristics of COVID-19 patients in Vietnam and a description of disease control and prevention measures in Thai Binh Province

COVID-19 in Vietnam: a lesson of pre-preparation

SARS-CoV-2 and co-infections detection in nasopharyngeal throat swabs of COVID-19 patients by metagenomics

The largest epicenter of the coronavirus outbreak in Vietnam

The first infant case of COVID-19 acquired from a secondary transmission in Vietnam

The first Vietnamese case of COVID-19 acquired from China

Outbreak investigation for COVID-19 in northern Vietnam

The natural history and transmission potential of asymptomatic SARS-CoV-2 infection

Diagnostic detection of 2019-nCoV by realtime RT-PCR. World Health Organization

An emergent clade of SARS-CoV-2 linked to returned travellers from Iran

SARS-CoV-2 Genome Sequencing Using Long Pooled Amplicons on Illumina Platforms 2020

Qualimap: evaluating next-generation sequencing alignment data

A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology

MAFFT online service: multiple sequence alignment, interactive sequence choice and visualization

RAxML version 8: a tool for phylogenetic analysis and post-analysis of large phylogenies

World Health Organization

Clinical characteristics of 138 hospitalized patients with 2019 novel coronavirus-infected pneumonia in Wuhan, China

Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study

A dynamic nomenclature proposal for SARS-CoV-2 to assist genomic epidemiology

Variant analysis of SARS-CoV-2 genomes

Tracking changes in SARS-CoV-2 Spike: evidence that D614G increases infectivity of the COVID-19 virus

Genetic diversity and evolution of SARS-CoV-2

We thank the technicians at the Department of Microbiology and Molecular, National Hospital for Tropical Diseases, in collecting clinical specimens; nurses and doctors in the various wards who recorded daily medical data. We especially thank our colleague at OUCRU-Ho Chi Minh city, Dr. Hong Thi Thu Nguyen, for guiding sequencing analyses in the early phase of the study. We are grateful to the submitters from many laboratories for the sequences on the GISAID database.